La Jolla, CA, United States of America

Norman R Klinman

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Altor Bioscience Corporation. Active years: 2003-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norman R Klinman. Retrieved from https://idiyas.com/inventor/norman-r-klinman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2003-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Norman R Klinman

Introduction

Norman R Klinman is a notable inventor based in La Jolla, California. He has made significant contributions to the field of biomedical research, particularly in the development of novel binding molecules. With a total of 2 patents to his name, Klinman's work has the potential to impact various therapeutic applications.

Latest Patents

Klinman's latest patents focus on polyspecific binding molecules. These inventions relate to single-chain polyspecific binding molecules that include at least one single-chain T-cell receptor (sc-TCR) covalently linked through a peptide linker sequence to at least one single-chain antibody (sc-Ab). The patents also disclose methods and compositions for testing and utilizing these innovative molecules.

Career Highlights

Klinman is currently associated with Altor Bioscience Corporation, where he continues to advance his research. His work is characterized by a commitment to developing cutting-edge solutions in the biomedical field.

Collaborations

Some of Klinman's notable coworkers include Linda A Sherman and Kimberlyn F Card. Their collaborative efforts contribute to the innovative environment at Altor Bioscience Corporation.

Conclusion

Norman R Klinman is a distinguished inventor whose work on polyspecific binding molecules showcases his dedication to advancing biomedical research. His contributions have the potential to lead to significant advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…